Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Charache S., Dover G., Smith K., Talbot C. C., Jr, Moyer M., Boyer S. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex. Proc Natl Acad Sci U S A. 1983 Aug;80(15):4842–4846. doi: 10.1073/pnas.80.15.4842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson F. L., Look A. T., Gockerman J., Ruggiero M. R., Dalla-Pozza L., Billings F. T., 3rd Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med. 1984 Sep 20;311(12):780–783. doi: 10.1056/NEJM198409203111207. [DOI] [PubMed] [Google Scholar]
- Letvin N. L., Linch D. C., Beardsley G. P., McIntyre K. W., Nathan D. G. Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. N Engl J Med. 1984 Apr 5;310(14):869–873. doi: 10.1056/NEJM198404053101401. [DOI] [PubMed] [Google Scholar]
- Ley T. J., DeSimone J., Anagnou N. P., Keller G. H., Humphries R. K., Turner P. H., Young N. S., Keller P., Nienhuis A. W. 5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia. N Engl J Med. 1982 Dec 9;307(24):1469–1475. doi: 10.1056/NEJM198212093072401. [DOI] [PubMed] [Google Scholar]
- Ley T. J., DeSimone J., Noguchi C. T., Turner P. H., Schechter A. N., Heller P., Nienhuis A. W. 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia. Blood. 1983 Aug;62(2):370–380. [PubMed] [Google Scholar]
- Nash G. B., Johnson C. S., Meiselman H. J. Mechanical properties of oxygenated red blood cells in sickle cell (HbSS) disease. Blood. 1984 Jan;63(1):73–82. [PubMed] [Google Scholar]
- Razin A., Riggs A. D. DNA methylation and gene function. Science. 1980 Nov 7;210(4470):604–610. doi: 10.1126/science.6254144. [DOI] [PubMed] [Google Scholar]
- Smith C. M., 2nd, Krivit W., White J. G. The irreversibly sickled cell. Am J Pediatr Hematol Oncol. 1982 Fall;4(3):307–315. [PubMed] [Google Scholar]
- Thomas E. D., Buckner C. D., Sanders J. E., Papayannopoulou T., Borgna-Pignatti C., De Stefano P., Sullivan K. M., Clift R. A., Storb R. Marrow transplantation for thalassaemia. Lancet. 1982 Jul 31;2(8292):227–229. doi: 10.1016/s0140-6736(82)90319-1. [DOI] [PubMed] [Google Scholar]
- Thomas E. D. Marrow transplantation for nonmalignant disorders. N Engl J Med. 1985 Jan 3;312(1):46–48. doi: 10.1056/NEJM198501033120110. [DOI] [PubMed] [Google Scholar]
- Torrealba-de Ron A. T., Papayannopoulou T., Knapp M. S., Fu M. F., Knitter G., Stamatoyannopoulos G. Perturbations in the erythroid marrow progenitor cell pools may play a role in the augmentation of HbF by 5-azacytidine. Blood. 1984 Jan;63(1):201–210. [PubMed] [Google Scholar]
- Wood W. G., Pembrey M. E., Serjeant G. R., Perrine R. P., Weatherall D. J. Hb F synthesis in sickle cell anaemia: a comparison of Saudi Arab cases with those of African origin. Br J Haematol. 1980 Jul;45(3):431–445. doi: 10.1111/j.1365-2141.1980.tb07163.x. [DOI] [PubMed] [Google Scholar]
